Quanterix Corporation

US$2.90As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:QTRXHealthcare
Country USA
PE (Fwd) •••
TSR 9Y CAGR (20.25%)
Div yield —
ROE (46.48%)
Medical Devices
Beta (5Y) 1.03
PE TTM —
TSR TTM (45.79%)
Mkt cap US$136.9M
ROIC (19.36%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$3.48
20.37%
52.97%
Hold 2|11|7|6|4
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.03
0.03
0.03
0.03
0.99%
3.50%
3.87%
3.47%
Revenue$M
13.85
14.33
14.27
14.04
1.65%
7.82%
6.81%
6.84%
Peers (US$136.9M)
Cap (US$)
PE
130.0M
—
121.9M
—
140.6M
42.87x
Capital
TTM
5Y
10Y
Leveragex
0.378
0.072
0.073
EBIT/Intx
1.196
1.900
1.887
Own earn%
51.56
(41.24)
(32.31)
Sh yield%
48.61
51.89
48.82
Owners
Insiders/Inst%
0.31
79.77
Short interest%
1.84
SBC / revenue%
2.94
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
22
Op margin range%
24–30
$1 testx
—
Incr. ROIC%
4